G39D (p.Gly39Asp) variant of FGB (Fibrinogen beta chain)

G39D (p.Gly39Asp) in FGB (Fibrinogen beta chain) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes structural context.

G39D (p.Gly39Asp) variant details